Table 5. Outcomes of allogeneic hematopoietic stem cell transplantation.
| Patient | 1 | 2 | 3 | 4 | 5 |
| Subtype | Acute | Acute | Acute | Acute | Lymphomatous |
| Lines of therapy | 3 | 1 | 1 | 5 | 3 |
| Disease status pre-transplant | PR | PR | CR | PD | PR |
| Graft | Haplo | MRD | MUD | MRD | MRD |
| Conditioning regimen | RIC | MA | RIC | RIC | RIC |
| Acute GVHD (Grade) | Skin (2) | GI (4) | GI, Skin (1) | GI (1) | GI (4) |
| Chronic GVHD | None | N/A | Skin | N/A | N/A |
| PFS | 14.4+ | 1.4 | 17.2+ | 3.7 | 3.4 |
| OS | 25.7+ | 7.6 | 28.4+ | 10.4 | 47.2 |
PFS is counted from day of stem cell infusion. OS is counted from index date. PR: partial response; CR: complete response; PD: progressive disease; Haplo: haploidentical donor; MRD: matched related donor; MUD: matched unrelated donor; RIC: reduced intensity conditioning; MA: myeloablative; GVHD: graft versus host disease; PFS: progression free survival; OS: overall survival.